Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
UBS
Fuji
AstraZeneca
Daiichi Sankyo
Cerilliant
McKesson
Argus Health
Federal Trade Commission

Generated: February 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018285

« Back to Dashboard

NDA 018285 describes VISKEN, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the VISKEN profile page.

The generic ingredient in VISKEN is pindolol. There are eleven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the pindolol profile page.
Summary for 018285
Tradename:VISKEN
Applicant:Novartis
Ingredient:pindolol
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Sep 3, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Sep 3, 1982TE:RLD:Yes

Expired US Patents for NDA 018285

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis VISKEN pindolol TABLET;ORAL 018285-001 Sep 3, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis VISKEN pindolol TABLET;ORAL 018285-002 Sep 3, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Baxter
Queensland Health
US Department of Justice
Dow
Federal Trade Commission
Merck
Farmers Insurance
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.